Health ❯ Chronic Diseases

Type 2 Diabetes

Heart Disease Obesity Treatment Options Obesity-Related Conditions Colorectal Cancer Medications Management Strategies Insulin Resistance Weight Management Risk Factors Prevention Strategies Risk Reduction Dietary Risk Factors Breast Cancer Risk Dementia Metabolic Disorders Insulin Sensitivity Metabolic Health Cardiovascular Risks GLP-1 Agonists Medication Insulin Regulation Management Medication Effects Obesity Treatment Obesity-related Conditions Comorbidities Hypertension Preventive Measures Cardiovascular Diseases Aspartame Prevention

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

Stories older than 24h

Gut Microbe Molecule TMA Inhibits IRAK4, Easing Diet-Driven Inflammation in Diabetes Models

Fatty Food Odors in Pregnancy Linked to Offspring Obesity Risk in Mouse Study

Brighter Nights Tied to Higher Cardiovascular Risk in 89,000-Person Wearable Study

7,000 Daily Steps Deliver Near-Maximal Health Benefits, Meta-Analysis Finds

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

New Meta-Analysis Finds No Safe Level of Ultra-Processed Foods

Metabolic Subtypes Drive Individual Blood Sugar Responses to Carbs, Study Finds